プロモーションスケジュール Laboratorios Farmaceuticos Rovi, S.A.
詳細なスケジュール
簡易グラフ
会社について
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. さらに詳しく| EBITDA | 0.0546 |
|---|---|
| EV/EBITDA | 0.2831 |
| Industry | Biotechnology |
| P/BV | 7.28 |
| P/E | 44.56 |
| P/S | 6.48 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Выручка | 0.3414 |
| Див.доход ао | 3.96 |
| Дивиденд ао | 2.11 |
| Сайт | https://www.rovi.es |
| Цена ао | 86.05 |
| Число акций ао | 0.05319 млрд |
| 1日あたりの価格変動: | 0% (90.61) |
|---|---|
| 週ごとの価格変動: | 0% (90.61) |
| 月ごとの料金変更: | 0% (90.61) |
| 3ヶ月間の価格変動: | 0% (90.61) |
| 半年間の価格変動: | 0% (90.61) |
| 年間の価格変動: | +74.25% (52) |
| 3年間の価格推移: | +31.8% (68.75) |
| 5年間の価格推移: | 0% (90.61) |
| 10年間の価格推移: | 0% (90.61) |
| 年初からの価格変動: | 0% (90.61) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Price (T.Rowe) International Discovery Fund | 830932 | 1.54 |
| Vanguard International Stock Index-Total Intl Stock Indx | 281370 | 0.52 |
| Victory Portfolios-Victory Trivalent International Small Cap Fund | 222468 | 0.41 |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 169903 | 0.31 |
| Price (T.Rowe) International Small-Cap Equity Trust | 134631 | 0.25 |
| iShares Core MSCI EAFE ETF | 114899 | 0.21 |
| DFA Continental Small Company Series | 113531 | 0.21 |
| DFA International Core Equity Portfolio | 104540 | 0.19 |
| iShares MSCI EAFE Small Cap ETF | 91619 | 0.17 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 83291 | 0.15 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Mr. Juan Lopez-Belmonte Encina | Chairman & CEO | 1.25M | |
| Mr. Ivan Lopez-Belmonte Encina | Second Deputy Chairman & GM of Commercial and Development | 505.46k | |
| Mr. Javier Lopez-Belmonte Encina | First Deputy Chairman, GM of Industrial Operations & CFO | 507.61k | |
| Marta Campos Martínez | Head of Investor Relations | N/A | |
| Ms. Mercedes Benítez del Castillo Sánchez | Legal Department Manager | N/A | |
| Ms. Rosario Perucha Pérez | Marketing Manager | N/A | |
| Mr. Francisco Javier Angulo García | Human Resources Manager | N/A | |
| Mr. Gabriel Nunez Fernandez | Secretary | N/A | |
| Ms. Beatriz Ávila Alcalde | Sales Manager | N/A |
